Literature DB >> 29892954

Analyses of karyotype by G-banding and high-resolution microarrays in a gender dysphoria population.

Rosa Fernández1,2, Antonio Guillamón3, Esther Gómez-Gil4, Isabel Esteva5, Mari Cruz Almaraz5, Joselyn Cortés-Cortés6, Beatriz Lamas6, Estefanía Lema7, Eduardo Pásaro6.   

Abstract

Gender Dysphoria is characterized by a marked incongruence between the cerebral sex and biological sex. To investigate the possible influence of karyotype on the etiology of Gender Dysphoria we carried out the cytogenetic analysis of karyotypes in 444 male-to-females (MtFs) and 273 female-to-males (FtMs) that attended the Gender Identity Units of Barcelona and Málaga (Spain) between 2000 and 2016. The karyotypes from 23 subjects (18 MtFs and 5 FtMs) were also analysed by Affymetrix CytoScan™ high-density (HD) arrays. Our data showed a higher incidence of cytogenetic alterations in Gender Dysphoria (2.65%) than in the general population (0.53%) (p < 0.0001). When G-banding was performed, 11 MtFs (2.48%) and 8 FtMs (2.93%) showed a cytogenetic alteration. Specifically, Klinefelter syndrome frequency was significantly higher (1.13%) (p < 0.0001), however Turner syndrome was not represented in our sample (p < 0.61). At molecular level, HD microarray analysis revealed a 17q21.31 microduplication which encompasses the gene KANSL1 (MIM612452) in 5 out of 18 MtFs and 2 out of 5 FtMs that corresponds to a copy-number variation region in chromosome 17q21.31. In conclusion, we confirm a significantly high frequency of aneuploidy, specifically Klinefelter syndrome and we identified in 7 out of 23 GD individuals the same microduplication of 572 Kb which encompasses the KANSL1 gene.

Entities:  

Keywords:  17q21.31 microduplication; Aneuploidy; Gender Dysphoria; KANSL1; Klinefelter syndrome

Mesh:

Substances:

Year:  2018        PMID: 29892954     DOI: 10.1007/s13258-017-0646-0

Source DB:  PubMed          Journal:  Genes Genomics        ISSN: 1976-9571            Impact factor:   1.839


  48 in total

1.  Birth order and ratio of brothers to sisters in transsexuals.

Authors:  R Green
Journal:  Psychol Med       Date:  2000-07       Impact factor: 7.723

2.  Sex chromosome aberrations and transsexualism.

Authors:  Markus Hengstschläger; Michael van Trotsenburg; Christa Repa; Erika Marton; Johannes C Huber; Gerhard Bernaschek
Journal:  Fertil Steril       Date:  2003-03       Impact factor: 7.329

3.  Hormone-treated transsexuals report less social distress, anxiety and depression.

Authors:  Esther Gómez-Gil; Leire Zubiaurre-Elorza; Isabel Esteva; Antonio Guillamon; Teresa Godás; M Cruz Almaraz; Irene Halperin; Manel Salamero
Journal:  Psychoneuroendocrinology       Date:  2011-09-19       Impact factor: 4.905

4.  Resolving the breakpoints of the 17q21.31 microdeletion syndrome with next-generation sequencing.

Authors:  Andy Itsara; Lisenka E L M Vissers; Karyn Meltz Steinberg; Kevin J Meyer; Michael C Zody; David A Koolen; Joep de Ligt; Edwin Cuppen; Carl Baker; Choli Lee; Tina A Graves; Richard K Wilson; Robert B Jenkins; Joris A Veltman; Evan E Eichler
Journal:  Am J Hum Genet       Date:  2012-04-06       Impact factor: 11.025

5.  Sex steroid-related genes and male-to-female transsexualism.

Authors:  Susanne Henningsson; Lars Westberg; Staffan Nilsson; Bengt Lundström; Lisa Ekselius; Owe Bodlund; Eva Lindström; Monika Hellstrand; Roland Rosmond; Elias Eriksson; Mikael Landén
Journal:  Psychoneuroendocrinology       Date:  2005-08       Impact factor: 4.905

6.  Discovery of previously unidentified genomic disorders from the duplication architecture of the human genome.

Authors:  Andrew J Sharp; Sierra Hansen; Rebecca R Selzer; Ze Cheng; Regina Regan; Jane A Hurst; Helen Stewart; Sue M Price; Edward Blair; Raoul C Hennekam; Carrie A Fitzpatrick; Rick Segraves; Todd A Richmond; Cheryl Guiver; Donna G Albertson; Daniel Pinkel; Peggy S Eis; Stuart Schwartz; Samantha J L Knight; Evan E Eichler
Journal:  Nat Genet       Date:  2006-08-13       Impact factor: 38.330

7.  Detection of low-level mosaicism by array CGH in routine diagnostic specimens.

Authors:  Blake C Ballif; Emily A Rorem; Kyle Sundin; Matt Lincicum; Shannon Gaskin; Justine Coppinger; Catherine D Kashork; Lisa G Shaffer; Bassem A Bejjani
Journal:  Am J Med Genet A       Date:  2006-12-15       Impact factor: 2.802

8.  High-resolution mapping and analysis of copy number variations in the human genome: a data resource for clinical and research applications.

Authors:  Tamim H Shaikh; Xiaowu Gai; Juan C Perin; Joseph T Glessner; Hongbo Xie; Kevin Murphy; Ryan O'Hara; Tracy Casalunovo; Laura K Conlin; Monica D'Arcy; Edward C Frackelton; Elizabeth A Geiger; Chad Haldeman-Englert; Marcin Imielinski; Cecilia E Kim; Livija Medne; Kiran Annaiah; Jonathan P Bradfield; Elvira Dabaghyan; Andrew Eckert; Chioma C Onyiah; Svetlana Ostapenko; F George Otieno; Erin Santa; Julie L Shaner; Robert Skraban; Ryan M Smith; Josephine Elia; Elizabeth Goldmuntz; Nancy B Spinner; Elaine H Zackai; Rosetta M Chiavacci; Robert Grundmeier; Eric F Rappaport; Struan F A Grant; Peter S White; Hakon Hakonarson
Journal:  Genome Res       Date:  2009-07-10       Impact factor: 9.043

9.  Mutations in the chromatin modifier gene KANSL1 cause the 17q21.31 microdeletion syndrome.

Authors:  David A Koolen; Jamie M Kramer; Kornelia Neveling; Willy M Nillesen; Heather L Moore-Barton; Frances V Elmslie; Annick Toutain; Jeanne Amiel; Valérie Malan; Anne Chun-Hui Tsai; Sau Wai Cheung; Christian Gilissen; Eugene T P Verwiel; Sarah Martens; Ton Feuth; Ernie M H F Bongers; Petra de Vries; Hans Scheffer; Lisenka E L M Vissers; Arjan P M de Brouwer; Han G Brunner; Joris A Veltman; Annette Schenck; Helger G Yntema; Bert B A de Vries
Journal:  Nat Genet       Date:  2012-04-29       Impact factor: 38.330

10.  Detection of low-level mosaicism and placental mosaicism by oligonucleotide array comparative genomic hybridization.

Authors:  Stuart A Scott; Ninette Cohen; Tracy Brandt; Gokce Toruner; Robert J Desnick; Lisa Edelmann
Journal:  Genet Med       Date:  2010-02       Impact factor: 8.822

View more
  2 in total

1.  Should chromosomal analysis be performed routinely during the baseline evaluation of the gender affirmation process? The outcomes of a large cohort of gender dysphoric individuals.

Authors:  Aysel Kalaycı Yigin; Şenol Turan; Mustafa Tarık Alay; Yasin Kavla; Öznur Demirel; Mehmet Seven
Journal:  Int J Impot Res       Date:  2022-05-17       Impact factor: 2.896

2.  Clinical features and prevalence of Klinefelter syndrome in transgender individuals: A systematic review.

Authors:  Bonnie Liang; Ada S Cheung; Brendan J Nolan
Journal:  Clin Endocrinol (Oxf)       Date:  2022-04-15       Impact factor: 3.523

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.